Value through InnovationMay 22 2013
  • Home
  • News & Events

Page content

jump to main navigation jump to meta navigation

Boehringer Ingelheim News Releases

Quick access to up-to-date company information.

Recent Press Releases

05.21.2013

Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at ATS 2013
05.17.2013

Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference

 -

For U.S. Media Only

05.17.2013

Transition to Propellant-Free Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray Nears Completion
05.15.2013

ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
05.15.2013

Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
view all press releases

Latest Event

2011

Drive 4 COPD
DRIVE4COPD

DRIVE4COPD is a national public health campaign that aims to find the "missing millions" of people who may have Chronic Obstrusive Pulmonary Disease (COPD) and don't even know it.

read more
back to top

US Headquarters Contact Information

  • Organisation
    Boehringer Ingelheim Pharmaceuticals, Inc.

    900 Ridgebury Rd.
    P.O. Box 368
    Ridgefield, CT 06877

Social Media